| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |